Endpoints News ٤ فبراير ٢٠٢٦ Embattled Novo Nordisk considers buying a monthly GLP-1 to bolster portfolio
Endpoints News ١٥ يناير ٢٠٢٦ FDA to meet Novo Nordisk on troubled site; AbbVie buys drug-device factory
Endpoints News ١٥ يناير ٢٠٢٦ Novo Nordisk Foundation to inject $850M+ into BioInnovation Institute through 2035
Endpoints News ١٢ يناير ٢٠٢٦ #JPM26: Novo Nordisk CEO says pharma can learn from the GLP-1 compounding boom
Endpoints News ٢٦ نوفمبر ٢٠٢٥ Novo’s MFN prices to supersede IRA prices for Ozempic, Wegovy, CMS says
Endpoints News ٢٥ نوفمبر ٢٠٢٥ Novo Nordisk’s amycretin cuts body weight, blood sugar in Phase 2 diabetes trial